Fujikawa H, Miyakawa H, Nagai K, Kako M
First Department of Pathology, Nihon University School of Medicine.
Nihon Rinsho. 1997 Mar;55(3):591-6.
We describe here interferon(IFN) and cyclosporine(CyA) therapy for GBV/HGV hepatitis. Up to the present, reported cases with IFN therapy in Japan were all most co-infected with chronic hepatitis C virus by retrospective studies. According to these results, IFN induced a transient decrease of serum GBV-C RNA levels during the administration, but, after the administration, these returned to levels at the pretreatment. We summarized in this review these therapeutic effects of previous reports in Japan. And, we reported our experienced case of GBV-C RNA-positive fulminant hepatitis treated with IFN and CyA. These observations induced that IFN was effective for decreasing serum levels of GBV-C RNA, and CyA was effective for increasing these levels. However, effects of IFN were transient. Therefore, we are planning re-treatment of IFN for this patient in near feature. Further study about the epidemical analysis of GBV-C/HGV hepatitis and therapeutic analysis of IFN for this disease are needed.
我们在此描述干扰素(IFN)和环孢素(CyA)治疗GBV/HGV肝炎的情况。截至目前,通过回顾性研究发现,日本报告的接受IFN治疗的病例大多同时合并慢性丙型肝炎病毒感染。根据这些结果,IFN在给药期间可使血清GBV-C RNA水平短暂下降,但给药后又恢复到治疗前水平。我们在本综述中总结了日本此前报告的这些治疗效果。并且,我们报告了1例用IFN和CyA治疗的GBV-C RNA阳性暴发性肝炎的病例。这些观察结果表明,IFN对降低血清GBV-C RNA水平有效,而CyA对提高这些水平有效。然而,IFN的作用是短暂的。因此,我们计划近期对该患者再次使用IFN进行治疗。需要进一步开展关于GBV-C/HGV肝炎的流行病学分析以及针对该疾病的IFN治疗分析的研究。